Medication info
Telmisartan, Rosuvastatin Calcium, Ezetimibe (Uncoated), Amlodipine Besylate Tablets 40/20/10/5 mg

Telmisartan, Rosuvastatin Calcium, Ezetimibe (Uncoated), Amlodipine Besylate Tablets 40/20/10/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletRosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tablet
Manufacturer / importer
Cheil Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
30 tablets/box [6 tablets/PTP X 5]
Approval status
Active

MFDS item code 202203052 · Approved 2022.07.21 · Insurance code 645406180

Summary

Main use
Treatment of hypertension and dyslipidemia (including hypercholesterolemia)
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Swallow the tablet whole; do not chew, divide, or crush it. ○ Telmisartan/Amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin/Ezetimibe Patients should follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10 mg to 20/10 mg once daily. The recommended starting dose is 5/10 mg once daily. The dose may be adjusted in patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, blood lipid levels should be checked at intervals of 4 weeks or more, and the dose adjusted accordingly. The dose may be increased up to a maximum of 20/10 mg daily. For patients taking the telmisartan/amlodipine combination together with the rosuvastatin/ezetimibe combination, switching to this medicine (a combination product with the same amounts of each active ingredient) may be considered for convenience.

Ingredients

Manufacturer
Cheil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and dyslipidemia (including hypercholesterolemia)

  • Essential hypertension
  • primary hypercholesterolemia
  • familial heterozygous hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used for patients who need to take a combination of telmisartan and amlodipine along with a combination of rosuvastatin and ezetimibe. It is primarily prescribed when both hypertension and dyslipidemia need to be treated together. Telmisartan and amlodipine are suitable for patients with essential hypertension who find it difficult to control blood pressure alone, and they help effectively manage blood pressure. Additionally, the combination of rosuvastatin and ezetimibe is used to improve cholesterol levels in patients with primary and mixed dyslipidemia. This medication lowers total cholesterol, LDL cholesterol, Apo B, and triglyceride levels while increasing HDL cholesterol levels, thereby aiding cardiovascular health. Therefore, this medication is used for patients requiring additional control of hypertension and dyslipidemia.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Swallow the tablet whole; do not chew, divide, or crush it. ○ Telmisartan/Amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin/Ezetimibe Patients should follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10 mg to 20/10 mg once daily. The recommended starting dose is 5/10 mg once daily. The dose may be adjusted in patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, blood lipid levels should be checked at intervals of 4 weeks or more, and the dose adjusted accordingly. The dose may be increased up to a maximum of 20/10 mg daily. For patients taking the telmisartan/amlodipine combination together with the rosuvastatin/ezetimibe combination, switching to this medicine (a combination product with the same amounts of each active ingredient) may be considered for convenience.

Precautions

This medication may cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so women who are pregnant or may become pregnant should avoid taking it. Patients with muscle-related diseases or severe liver or kidney dysfunction should not use this medication, and it should not be administered to individuals with allergies to any component of the medication. Before taking this medication, liver and kidney function tests should be performed, and if abnormalities are found, a doctor should be consulted. Regular tests should also be conducted during treatment. If symptoms such as muscle pain, weakness, fatigue, or fever occur, a doctor should be notified immediately for examination, and in severe cases, discontinuation of the medication may be necessary. If blood pressure drops too low or symptoms such as dizziness or fainting occur, it is essential to consult a doctor immediately. Hyperkalemia (increased potassium levels in the blood) may occur, so potassium levels should be checked regularly, and caution is needed when using potassium supplements or medications containing potassium. There may be interactions with other medications, so if any other medications are currently being taken, healthcare professionals must be informed, especially with respect to lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs. Caution is required during driving or operating machinery as dizziness or drowsiness may occur. This medication contains specific pigments and should not be administered to patients with lactose intolerance or certain genetic diseases. If sudden breathing difficulties or swelling of the face, lips, or tongue occur, the medication should be stopped immediately, and emergency treatment should be sought. Patients with heart failure or cardiovascular diseases should use this medication cautiously, especially if they have very low blood pressure or weak heart function. If any unusual symptoms arise during treatment, immediate consultation with a healthcare professional is essential for appropriate action.

Side effects

Eyelid damage, head injury, dysuria, flushing, chronic gastritis, various gastrointestinal disorders, hiatal hernia, facial edema, strange sensation, drug intolerance, chest pain, irritable bowel syndrome, colon polyps, esophagitis, dizziness, drowsiness, neurodegenerative disorders, positional vertigo, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal obstruction, respiratory distress, pelvic pain, breast cyst, eyelid ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, upper respiratory tract infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal distension, vomiting, abdominal discomfort, dry mouth, liver function abnormalities, liver dysfunction, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, asthenia, influenza-like illness, increased serum creatinine, increased serum uric acid, elevated liver enzymes, increased serum creatine kinase, decreased hemoglobin, angioedema, vasculitis, tension headache, sensory decrease, sensory abnormalities, peripheral neuropathy, taste abnormalities, tremor, extrapyramidal disorders, erectile dysfunction, changes in bowel habits, gingival hyperplasia, pancreatitis, headache, drowsiness, fatigue, edema, palpitations, vertigo, nausea, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, myocardial infarction, arrhythmia, sinoatrial block, atrioventricular block, precordial pain, loose stools, constipation, skin flushing, maculopapular rash, heaviness, heat sensation, impaired glucose tolerance, weakness, petechiae, constipation, nausea, pancreatitis, myopathy, rhabdomyolysis, weakness, lethargy, weight gain, weight loss, headache, facial spasms, sensory abnormalities, paralysis, hyperventilation, pneumonia, rash, alopecia, conjunctivitis, tinnitus, osteoarthritis, myalgia, myopathy, myositis, muscle rupture, muscle cramps, muscle weakness, arthralgia, joint pain, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, jaundice, hepatitis, hepatic toxicity, acute hepatitis, toxic hepatitis, hepatitis, liver function abnormalities, abnormal liver function tests, interstitial pneumonia, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, cholelithiasis, cholecystitis, renal failure, increased serum creatinine, elevated blood pressure, increased serum urea, increased CPK, abnormal liver function tests, thrombocytopenia, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), immune-mediated necrotizing myopathy, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, urticaria, hyperhidrosis, rash, itching, upper respiratory tract infection, conjunctival injection, renal failure, hepatitis, headache, dizziness, elevated ALT, chest pain, cough, myalgia, elevated CK, constipation, asthenia, arthralgia, fatigue, numbness, sensory abnormalities, nausea, abdominal pain, diarrhea, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the medication's effectiveness.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets/box [6 tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.